AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036
13/05/2024 – AB Science today announced that the European patent office has issued a Grant Decision for a patent relating to methods of treating severe mastocytosis with its lead compound masitinib